Vom CCC unterstützte Publikationen 2022
Basal cell carcinoma of the prostate: a case report responding to the FGFR inhibitor pemigatinib and literature review
Rebhan, K., Wasinger, G., Hassler, M. R., Shariat, S. F., & Compérat, E. M. (2022). Basal cell carcinoma of the prostate: a case report responding to the FGFR inhibitor pemigatinib and literature review. Current opinion in urology, 32(4), 358–363. doi.org/10.1097/MOU.0000000000001007
Nonmuscle-invasive bladder cancer, old problems, new insights
Compérat, E., Wasinger, G., Oszwald, A., Pradere, B., & Shariat, S. (2022). Nonmuscle-invasive bladder cancer, old problems, new insights. Current opinion in urology, 32(4), 352–357. doi.org/10.1097/MOU.0000000000000997
Device-assisted intravesical chemotherapy treatment for nonmuscle invasive bladder cancer: 2022 update
Vartolomei, M. D., Ferro, M., Roth, B., Teoh, J. Y., Gontero, P., & Shariat, S. F. (2022). Device-assisted intravesical chemotherapy treatment for nonmuscle invasive bladder cancer: 2022 update. Current opinion in urology, 10.1097/MOU.0000000000001010. Advance online publication. doi.org/10.1097/MOU.0000000000001010
International Alliance of Urolithiasis (IAU) Guideline on Retrograde Intrarenal Surgery
Zeng, G., Traxer, O., Zhong, W., Osther, P., Pearle, M. S., Preminger, G. M., Mazzon, G., Seitz, C., Geavlete, P., Fiori, C., Ghani, K. R., Chew, B. H., Git, K. A., Vicentini, F. C., Papatsoris, A., Brehmer, M., Martinez, J. L., Cheng, J., Cheng, F., Gao, X., … Sarica, K. (2022). International Alliance of Urolithiasis (IAU) Guideline on Retrograde Intrarenal Surgery. BJU international, 10.1111/bju.15836. Advance online publication. doi.org/10.1111/bju.15836
Nationwide lung cancer screening with low-dose computed tomography: implementation and first results of the HUNCHEST screening program
Kerpel-Fronius, A., Monostori, Z., Kovacs, G., Ostoros, G., Horvath, I., Solymosi, D., Pipek, O., Szatmari, F., Kovacs, A., Markoczy, Z., Rojko, L., Renyi-Vamos, F., Hoetzenecker, K., Bogos, K., Megyesfalvi, Z., & Dome, B. (2022). Nationwide lung cancer screening with low-dose computed tomography: implementation and first results of the HUNCHEST screening program. European radiology, 32(7), 4457–4467. doi.org/10.1007/s00330-022-08589-7
Lymphocyte-to-monocyte ratio is an independent prognostic factor in surgically treated small cell lung cancer: An international multicenter analysis
Lang, C., Egger, F., Alireza Hoda, M., Saeed Querner, A., Ferencz, B., Lungu, V., Szegedi, R., Bogyo, L., Torok, K., Oberndorfer, F., Klikovits, T., Schwendenwein, A., Boettiger, K., Renyi-Vamos, F., Hoetzenecker, K., Schelch, K., Megyesfalvi, Z., & Dome, B. (2022). Lymphocyte-to-monocyte ratio is an independent prognostic factor in surgically treated small cell lung cancer: An international multicenter analysis. Lung cancer (Amsterdam, Netherlands), 169, 40–46. doi.org/10.1016/j.lungcan.2022.05.010
Independent validation of stromal uPA in ABCSG-08: Level 1b evidence for the prognostic value of uPA immunohistochemistry
Singer, C. F., Jahn, S. W., Rudas, M., Bago-Horvath, Z., Fitzal, F., Abete, L., Moinfar, F., Gnant, M., Filipits, M., & Austrian Breast and Colorectal Cancer Study Group (ABCSG) (2022). Independent validation of stromal uPA in ABCSG-08: Level 1b evidence for the prognostic value of uPA immunohistochemistry. Breast (Edinburgh, Scotland), 64, 127–133. Advance online publication. doi.org/10.1016/j.breast.2022.05.003
The iTOP trial: Comparing immediate techniques of oncoplastic surgery with conventional breast surgery in women with breast cancer - A prospective, controlled, single-center study
Bolliger, M., Lanmüller, P., Schuetz, M., Heilig, B., Windischbauer, A., Jakesz, R., Zehetgruber, T., Gnant, M., Gleiss, A., Dörfler, D., Singer, C., Bartsch, R., Haslik, W., Montagna, G., & Fitzal, F. (2022). The iTOP trial: Comparing immediate techniques of oncoplastic surgery with conventional breast surgery in women with breast cance - A prospective, controlled, single-center study. International journal of surgery (London, England), 106694. Advance online publication. https://doi.org/10.1016/j.ijsu.2022.106694
Metastatic stage vs complications at radical nephrectomy with inferior vena cava thrombectomy
Hoeh, B., Flammia, R. S., Hohenhorst, L., Sorce, G., Panunzio, A., Chierigo, F., Nimer, N., Tian, Z., Saad, F., Gallucci, M., Briganti, A., Shariat, S. F., Graefen, M., Tilki, D., Antonelli, A., Terrone, C., Kluth, L. A., Becker, A., Chun, F., & Karakiewicz, P. I. (2022). Metastatic stage vs complications at radical nephrectomy with inferior vena cava thrombectomy. Surgical oncology, 42, 101783. doi.org/10.1016/j.suronc.2022.101783
The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD) and ... (EFC) consensus statement on pre-invasive vulvar lesions
Preti, M., Joura, E., Vieira-Baptista, P., Van Beurden, M., Bevilacqua, F., Bleeker, M., Bornstein, J., Carcopino, X., Chargari, C., Cruickshank, M. E., Erzeneoglu, B. E., Gallio, N., Heller, D., Kesic, V., Reich, O., Stockdale, C. K., Esat Temiz, B., Woelber, L., Planchamp, F., Zodzika, J., … Gultekin, M. (2022). The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD) and the European Federation for Colposcopy (EFC) consensus statements on pre-invasive vulvar lesions. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, ijgc-2021-003262. Advance online publication. doi.org/10.1136/ijgc-2021-003262
Clickable Cisplatin Derivatives as Versatile Tools to Probe the DNA Damage Response to Chemotherapy
Moretton, A., Slyskova, J., Simaan, M. E., Arasa-Verge, E. A., Meyenberg, M., Cerrón-Infantes, D. A., Unterlass, M. M., & Loizou, J. I. (2022). Clickable Cisplatin Derivatives as Versatile Tools to Probe the DNA Damage Response to Chemotherapy. Frontiers in oncology, 12, 874201. doi.org/10.3389/fonc.2022.874201
Diagnostic Performance of Prostate-specific Membrane Antigen Positron Emission Tomography-targeted biopsy for Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysis
Kawada, T., Yanagisawa, T., Rajwa, P., Sari Motlagh, R., Mostafaei, H., Quhal, F., Laukhtina, E., Aydh, A., König, F., Pallauf, M., Pradere, B., Ceci, F., Baltzer, P., Hacker, M., Rasul, S., Karakiewicz, P. I., Araki, M., Nasu, Y., & Shariat, S. F. (2022). Diagnostic Performance of Prostate-specific Membrane Antigen Positron Emission Tomography-targeted biopsy for Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysis. European urology oncology, S2588-9311(22)00064-5. Advance online publication. https://doi.org/10.1016/j.euo.2022.04.006
Ovarian Function Suppression: A Deeper Consideration of the Role in Early Breast Cancer and its Potential Impact on Patient Outcomes: A Consensus Statement from an International Expert Panel
Arboleda, B., Bartsch, R., de Azambuja, E., Hamilton, E., Harbeck, N., Klemp, J., Knauer, M., Kuemmel, S., Mahtani, R., Schwartzberg, L., Villarreal-Garza, C., & Wolff, A. (2022). Ovarian Function Suppression: A Deeper Consideration of the Role in Early Breast Cancer and its Potential Impact on Patient Outcomes: A Consensus Statement from an International Expert Panel. The oncologist, oyac101. Advance online publication. https://doi.org/10.1093/oncolo/oyac101
Selecting the Best Candidates for Cisplatin-based Adjuvant Chemotherapy After Radical Cystectomy Among Patients with pN+ Bladder Cancer
Afferi, L., Lonati, C., Montorsi, F., Briganti, A., Necchi, A., Mari, A., Minervini, A., Tellini, R., Campi, R., Schulz, G. B., Black, P. C., di Trapani, E., de Cobelli, O., Karnes, R. J., Ahmed, M., Mir, M. C., Algarra, M. A., Rink, M., Zamboni, S., Mondini, F., … European Association of Urology Young Academic Urologists Urothelial Carcinoma Working Group (2022). Selecting the Best Candidates for Cisplatin-based Adjuvant Chemotherapy After Radical Cystectomy Among Patients with pN+ Bladder Cancer. European urology oncology, S2588-9311(22)00062-1. Advance online publication. https://doi.org/10.1016/j.euo.2022.04.001
Bendamustine is Safe and Effective for Lymphodepletion Before Tisagenlecleucel in Patients with Refractory or Relapsed Large B-Cell Lymphomas
Ghilardi, G., Chong, E. A., Svoboda, J., Wohlfarth, P., Nasta, S. D., Williamson, S., Landsburg, J. D., Gerson, J. N., Barta, S. K., Pajarillo, R., Myers, J., Chen, A. I., Schachter, L., Yelton, R., Ballard, H. J., Hodges Dwinal, A., Gier, S., Victoriano, D., Weber, E., Napier, E., … Schuster, S. J. (2022). Bendamustine is Safe and Effective for Lymphodepletion Before Tisagenlecleucel in Patients with Refractory or Relapsed Large B-Cell Lymphomas. Annals of oncology : official journal of the European Society for Medical Oncology, S0923-7534(22)01722-7. Advance online publication. doi.org/10.1016/j.annonc.2022.05.521
Neoadjuvant Immunotherapy in Gastrointestinal Cancers - The New Standard of Care?
Petricevic, B., Kabiljo, J., Zirnbauer, R., Walczak, H., Laengle, J., & Bergmann, M. (2022). Neoadjuvant Immunotherapy in Gastrointestinal Cancers - The New Standard of Care?. Seminars in cancer biology, S1044-579X(22)00126-2. Advance online publication. https://doi.org/10.1016/j.semcancer.2022.05.015
Estimating Bleeding Risk in Patients with Cancer-Associated Thrombosis: Evaluation of Existing Risk Scores and Development of a New Risk Score
de Winter, M. A., Dorresteijn, J., Ageno, W., Ay, C., Beyer-Westendorf, J., Coppens, M., Klok, F. A., Moustafa, F., Riva, N., Ruiz Artacho, P. C., Vanassche, T., & Nijkeuter, M. (2022). Estimating Bleeding Risk in Patients with Cancer-Associated Thrombosis: Evaluation of Existing Risk Scores and Development of a New Risk Score. Thrombosis and haemostasis, 122(5), 818–829. doi.org/10.1055/s-0041-1735251
Unanswered questions in cancer-associated thrombosis
Sanfilippo, K. M., Moik, F., Candeloro, M., Ay, C., Di Nisio, M., & Lee, A. (2022). Unanswered questions in cancer-associated thrombosis. British journal of haematology, 10.1111/bjh.18276. Advance online publication. https://doi.org/10.1111/bjh.18276
Influence of Height on Risk and Outcome of Patients with Early Breast Cancer: A Pooled Analysis of 4,925 Patients from 5 Randomized Trials of the Austrian Breast and Colorectal Cancer Study Group (ABCSG)
Gampenrieder, S. P., Pircher, M., Fesl, C., Rinnerthaler, G., Mlineritsch, B., Greil-Ressler, S., Steger, G. G., Sagaster, V., Fitzal, F., Exner, R., Devyatko, Y., Balic, M., Stöger, H., Suppan, C., Bauernhofer, T., Singer, C. F., Pfeiler, G., Seifert, M., Helfgott, R., Heck, D., … Greil, R. (2022). Influence of Height on Risk and Outcome of Patients with Early Breast Cancer: A Pooled Analysis of 4,925 Patients from 5 Randomized Trials of the Austrian Breast and Colorectal Cancer Study Group (ABCSG). Breast care (Basel, Switzerland), 17(2), 137–145. doi.org/10.1159/000516157
Application of mTORC1 Inhibitors for Tissue-Agnostic Management of Standard-Therapy-Refractory Solid Tumors.
Taghizadeh H, Maj-Hes A, Prager GW, Müllauer L, Mader RM. Application of mTORC1 Inhibitors for Tissue-Agnostic Management of Standard-Therapy-Refractory Solid Tumors. Cancers (Basel). 2022 Apr 12;14(8):1936. doi.org/10.3390/cancers14081936 PMID: 35454843; PMCID: PMC9032789.
Neoadjuvant chemoradiotherapy is superior to chemotherapy alone in surgically treated stage III/N2 non-small-cell lung cancer: a retrospective single-center cohort study
Sinn, K., Mosleh, B., Steindl, A., Zoechbauer-Mueller, S., Dieckmann, K., Widder, J. ,Steiner, E., Klepetko, W., Hoetzenecker, K., Laszlo, V., Doeme, B., Klikovits, T., & Hoda, M. A. (2022). Neoadjuvant chemoradiotherapy is superior to chemotherapy alone in surgically treated stage III/N2 non-small-cell lung cancer: a retrospective single-center cohort study. ESMO open, 7(2), 100466. https://doi.org/10.1016/j.esmoop.2022.100466
